Diabetes and Alzheimer's Disease

Epidemiological data indicates that a significant portion of the diabetic population exhibits brain changes that are hallmarks of Alzheimer’s disease and vascular dementia. However, direct biological links remain incompletely understood. Here is the latest research.

June 26, 2020

Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study

Neurology
Aneela RahmanLisa Mosconi
July 3, 2020
Review

Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Adam B EdwardsBruno P Meloni
June 27, 2020
Open Access

Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells

Scientific Reports
Prashant BharadwajPhilip Newsholme
July 1, 2020

Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats

Fundamental & Clinical Pharmacology
Adel A GomaaMariam A Nicola
June 23, 2020

Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases

Journal of Magnetic Resonance Imaging : JMRI
Dengrong JiangHanzhang Lu
July 1, 2020

Diabetes mellitus and cognitive impairment

Terapevticheskiĭ arkhiv
E V SurkovaA V Naminov
July 12, 2020

Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N  =  395,769)

Journal of Alzheimer's Disease : JAD
Amy C FergusonDonald M Lyall
July 4, 2020
Review

Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions

Journal of Ginseng Research
Muhammad IrfanMan Hee Rhee
July 1, 2020

Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice

Brain Research Bulletin
Yun CaoXinwen Zhou
June 26, 2020
Open Access

The Role of Glycation on the Aggregation Properties of IAPP

Frontiers in Molecular Biosciences
Giulia MilordiniAnnalisa Pastore
July 7, 2020

Helix Dipole and Membrane Electrostatics Delineate Conformational Transitions in the Self-assembly of Amyloidogenic Peptides

Langmuir : the ACS Journal of Surfaces and Colloids
Qiuchen ZhengNoel D Lazo
July 11, 2020

Value of a Panel of 6 Serum Biomarkers to Differentiate between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease

Alzheimer Disease and Associated Disorders
Carola G SchipkeTimo Grimmer

Sign up to follow this feed and discover related papers.

Related Feeds

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Aging Genetics

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

Alzheimer's Disease: APP

Amyloid precursor protein proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques. Here is the latest research.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Alzheimer's Disease: Animal models

Alzheimer's disease is a chronic neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Early Markers

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alzheimer's Disease: Endosomes

The feed focuses on the role of dysfunctional endosomal trafficking in Alzheimer’s Disease and the potential for targeting the endosome as a therapeutic target.

© 2020 Meta ULC. All rights reserved
/feed-previews/diabetes-and-alzheimers-disease/1fd339f4-7778-4cc3-82b4-3f71b2b8f654